 |
H-028631 |
3-methyl-6-(4,4,5,5-tetramethyl-(1,3,2)dioxaborolan-2-yl)-[1,2,4]triazolo(4,3-a)pyridine
CAS NO.：1231934-47-6 |
O) |
H-028632 |
(2-(2-morpholinoethoxy)phenyl)boronic acid
CAS NO.：1310930-78-9 |
C(C)(C)OB(C2%3dCC%3dCC%3dC2OCCN3CCCC3)O1) |
H-028633 |
1-(2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine
CAS NO.：2246759-20-4 |
 |
H-028634 |
1-methyl-4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine
CAS NO.：910462-34-9 |
 |
H-028636 |
ethyl 6-bromo-1H-benzo[d]imidazole-2-carboxylate
CAS NO.：144167-50-0 |
C%3dC1)%3dN) |
H-028637 |
1-(4-iodophenyl)guanidine
CAS NO.：45964-99-6 |
%3dN) |
H-028638 |
1-(2-iodophenyl)guanidine
CAS NO.：1251246-60-2 |
 |
H-028639 |
1-(3-nitrophenyl)guanidine
CAS NO.：142992-99-2 |
NC1C%3dCC(N)%3dCC%3d1.O%5bN%2b%5d(%3dO)%5bO-%5d) |
H-028640 |
1-(4-aminophenyl)guanidine nitrate
CAS NO.：7152-55-8 |
%3dC1)%3dN) |
H-028641 |
1-(m-tolyl)guanidine
CAS NO.：45964-03-8 |
 |
H-028642 |
1-(o-tolyl)guanidine
CAS NO.：37557-40-7 |
 |
H-028643 |
1-(3-(trifluoromethyl)phenyl)guanidine
CAS NO.：71198-37-3 |
%3dN%2fC1%3dCC%3dCC%3dC1C(F)(F)F) |
H-028644 |
2-(2-(trifluoromethyl)phenyl)guanidine
CAS NO.：41213-66-5 |
 |
H-028645 |
2-(3,4-dimethoxyphenyl)guanidine
CAS NO.：57004-61-2 |
 |
H-028646 |
4-(2-chloroethoxy)aniline
CAS NO.：27692-35-9 |
(C)C)NC1%3dCC%3dCC(Br)%3dC1F) |
H-028647 |
tert-butyl (3-bromo-2-fluorophenyl)carbamate
CAS NO.：848440-23-3 |
 |
H-028648 |
N-(4-bromobenzyl)-N-ethylethanamine
CAS NO.：4885-19-2 |
CC) |
H-028651 |
N-(2-bromobenzyl)-N-ethylethanamine
CAS NO.：91428-19-2 |
 |
H-028652 |
4-(2-(4-bromophenoxy)ethyl)morpholine
CAS NO.：836-59-9 |
 |
H-028653 |
4-(2-(3-bromophenoxy)ethyl)morpholine
CAS NO.：435283-95-7 |
 |
H-028654 |
1-(2-(3-bromophenoxy)ethyl)pyrrolidine
CAS NO.：23136-18-7 |
